Related Experiment Video
Updated: Jun 8, 2026
10:12
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
[From stem cells to functional beta cells in type 1 diabetes].
Nina Engberg1, Mattias Hansson, Ole D Madsen
1Hagedorn Forskningsinstitut, Afdeling for Stamcellebiologi, Gentofte, Denmark.
Ugeskrift for Laeger
|October 6, 2010
Summary
Stem cell therapy offers a promising alternative for type 1 diabetes treatment by generating functional beta-cells. However, critical challenges must be addressed for successful clinical translation of these advanced stem cell therapies.
Area of Science:
- Endocrinology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Type 1 diabetes (T1D) treatment aims to restore glucose homeostasis by replacing lost insulin-producing beta-cells.
- Islet transplantation is limited by donor tissue scarcity, hindering widespread cell replacement therapy.
- Stem cells offer a potential alternative source for generating therapeutic beta-cells.
Purpose of the Study:
- To review the potential of stem cells for generating functional beta-cells for T1D treatment.
- To identify critical challenges hindering the clinical application of stem cell-based therapies for T1D.
Main Methods:
- Directed differentiation of stem cells towards a beta-cell fate.
- Stepwise recapitulation of embryonic developmental processes.
- Analysis of key obstacles in clinical translation.
Main Results:
- Stem cell differentiation protocols can generate beta-like cells, mimicking embryonic development.
- Significant hurdles remain in achieving a functional beta-cell mass and ensuring long-term efficacy.
- Regulatory, safety, and scalability issues impede clinical translation.
Conclusions:
- Stem cells hold promise as a renewable source for beta-cell replacement in T1D.
- Overcoming critical challenges is essential for the successful clinical implementation of stem cell therapies.
- Further research is needed to translate laboratory advancements into effective T1D treatments.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...